Brighton Jones’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Brighton Jones's AXSM Position: Q3 2026 in Review
Brighton Jones sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 858 shares — an estimated $210K sold.
Brighton Jones first reported a position in AXSM in Q2 2026 and held it in 1 quarter. The position peaked at $210K in Q2 2026. 385 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Brighton Jones reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 858 Axsome Therapeutics shares in Q3 2026, an estimated $210K.
- Brighton Jones first reported a position in Axsome Therapeutics in Q2 2026 and held it in 1 quarter.
- Brighton Jones's Axsome Therapeutics position peaked at $210K in Q2 2026.
- 385 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.